Top 50 Ai For Genomics in Latin America

The startup develops personalized pharmaceutical technology that tailors medication regimens based on individual patient profiles, enhancing therapeutic efficacy and minimizing adverse effects. By utilizing advanced data analytics and pharmacogenomics, the company aims to improve patient outcomes and overall quality of life.

Clear Labs is a biotechnology firm that utilizes a genomics system to enhance diagnostic accuracy in clinical and application sectors. The company addresses the complexity of traditional diagnostic processes by providing streamlined genomic analysis, enabling faster and more reliable results.

The startup specializes in identifying bioactive ribonucleic acid (RNA) from natural sources using machine learning and bioinformatics techniques. This enables researchers to enhance human health and resilience in response to environmental stressors through the application of RNA technologies.

MEDiC utilizes a proprietary CRISPR functional genomics platform combined with 3D tumor models to identify cancer biomarkers and novel drug targets with high precision. This approach addresses the challenge of missed potential biomarkers in current drug development, enhancing the accuracy of patient stratification for oncology treatments.

Elegen utilizes proprietary cell-free DNA synthesis technology to produce long, complex, linear DNA up to 7 kb with 99.999% accuracy, eliminating the need for cloning. This rapid synthesis, delivered in 6 to 8 business days, addresses the critical bottleneck in DNA supply for synthetic biology applications, significantly reducing project timelines and costs.

Precision Data provides a business intelligence platform that utilizes generative artificial intelligence to optimize access to over 8 billion lines of structured clinical data, enhancing real-world evidence studies in healthcare. The company addresses the challenge of data quality and accessibility, enabling healthcare organizations to make informed decisions based on accurate and comprehensive information.

Nintx Next Innovative Therapeutics utilizes proprietary technologies such as xGIbiomics, which simulates the human gastrointestinal system, and GAIApath, an AI-driven analytics platform, to identify and develop plant-based therapies targeting multifactorial diseases. By leveraging Brazil's rich biodiversity, Nintx aims to create multi-target therapies that modulate human biological systems and the microbiome, addressing the limitations of traditional single-target drug approaches.

metaBIX Biotech has developed a platform that utilizes hardware, biotechnology, and artificial intelligence to monitor airborne pathogens, providing early warnings of potential disease outbreaks in plants, animals, and humans. This technology enables clients to implement preventive measures at least two weeks before an outbreak occurs, enhancing safety and public health.

Onc.AI develops an AI-powered clinical management platform that utilizes a comprehensive oncology real-world dataset, including diagnostic imaging and genomics, to enhance treatment decision-making for metastatic lung cancer patients undergoing PD-1 immunotherapy. The platform provides actionable insights that enable oncologists to improve patient outcomes by optimizing treatment strategies based on real-world evidence.

The startup develops an artificial intelligence-based respiratory health monitoring system that analyzes individual and population-level respiratory data to track disease progression and treatment outcomes. This technology enables healthcare providers to implement timely interventions for patients with respiratory illnesses, improving overall care quality.

Cache DNA is developing a wet operating system for the storage and retrieval of biomolecules, utilizing scalable nucleic acid storage techniques to preserve biological data indefinitely. This technology addresses the challenge of data loss by enabling the long-term retention of both digital and biological information without the need for deletion.

Onward Assist is a predictive analytics platform that utilizes AI-driven image analysis to enhance cancer diagnosis by identifying biomarkers and reducing reporting time by 30-40%. The platform addresses the lack of effective cancer scoring tools tailored for diverse populations, enabling pathologists to make more accurate treatment decisions efficiently.

This food technology company utilizes AI algorithms to create plant-based meat and dairy alternatives from ingredients like pineapple, coconut, and chickpeas, replicating the taste and texture of animal products. Their offerings provide a sustainable source of fiber, calcium, and protein, addressing the demand for healthier and environmentally friendly food options.

Embryoxite develops an AI-powered platform that analyzes embryo metabolomic data, genetic profiles, and morphokinetic imaging to assess implantation potential in pre-implantation embryos. This technology addresses the high failure rate of embryo implantation in IVF procedures by providing objective, data-driven insights that enhance selection accuracy and improve pregnancy outcomes.

The startup is developing a Clinical Digital Twin Platform that creates virtual replicas of patients using real-time health data and advanced modeling techniques. This platform enables healthcare providers to personalize treatment plans and improve patient outcomes by simulating various clinical scenarios.

VivaWell provides a digital health and wellness platform that uses AI and data science to deliver personalized health programs and quality healthcare. It helps individuals and organizations improve health outcomes and manage healthcare costs through tailored services and population health insights.

The startup develops an AI-driven health tech software that enhances patient-clinic interactions through personalized and secure communication. This solution improves patient engagement and adherence to treatment, leading to better health outcomes in healthcare settings.

Cromai utilizes artificial intelligence to analyze agricultural images for precise identification and quantification of invasive plant species, enabling targeted herbicide application. This technology reduces herbicide usage by up to 65%, enhancing operational efficiency and sustainability in crop management.

This biotech startup produces highly pure enzymes using recombinant DNA repair technology derived from Antarctic extremophiles, enabling large-scale replication of active ingredients. Their offerings provide clinicians with effective alternatives for skin health and rejuvenation in the cosmetic and pharmaceutical industries.

Gennie is a generative AI platform that accelerates the product development process by over 10 times, utilizing advanced methodologies in Design Thinking and innovation processes. It addresses the lengthy time-to-market challenge by refining concepts early in the development cycle, enabling businesses to validate ideas more efficiently.

TAXON utilizes artificial intelligence and genomic analysis to enhance soil microbiome understanding, enabling farmers and biotech companies to optimize crop yields and reduce reliance on agrochemicals. By providing detailed insights into microbial diversity and functionality, TAXON helps clients make informed decisions that lead to sustainable agricultural practices and improved productivity.

Huna develops an AI engine that analyzes routine blood test data to identify risk patterns for early cancer detection and other chronic diseases. This technology enables healthcare providers to classify patients by risk level, improving clinical decision-making and increasing the chances of successful treatment while reducing overall healthcare costs.

This biotechnology platform decodes microbiomes to identify and manage their potential in productive environments. By providing insights from microbiome data, the platform helps researchers make informed decisions to minimize environmental impact and enhance performance.

Arkangel AI is a no-code platform that transforms medical data into AI algorithms for early disease detection, enabling healthcare organizations to build and deploy tailored solutions efficiently. By streamlining processes such as patient triage and drug adverse effect prediction, Arkangel AI enhances healthcare outcomes while significantly reducing operational costs.

Rosebud Biosciences develops targeted therapies for rare genetic diseases in children by utilizing organoids that replicate specific genetic mutations, allowing for precise drug screening. This approach addresses the critical lack of approved treatments for 95% of rare diseases, significantly improving the potential for effective cures.

Genloops provides enterprises with customized large language models (LLMs) that are privately hosted on their infrastructure, significantly reducing costs by up to 90% compared to traditional GPT-4 usage. The platform enables seamless integration of tailored LLMs into existing workflows, ensuring data privacy and high-performance solutions that adapt to specific business needs.

The startup develops a generative artificial intelligence-based medical record system that automates healthcare billing by accurately reading documents and performing billing calculations. This technology reduces errors and processing time, enabling clinics and laboratories to enhance the efficiency of their medical billing operations.

The startup is a learning platform that connects software developers to collaboratively create digital products through shared coding environments and version control systems. This approach addresses the challenge of fragmented development efforts by facilitating real-time collaboration and knowledge exchange among developers.

This agricultural bioscience company develops gene identification and characterization technologies to enhance crop yields and improve food security. By validating discoveries in prototype plants and forming partnerships with seed companies, they enable clients to maintain agricultural productivity amid climate challenges.

Aperture Therapeutics develops a drug discovery engine that utilizes extensive cell libraries representing genetic diversity to identify gene variants that confer protection against neurodegenerative diseases. By targeting specific RNA transcripts, the company aims to create therapies that can delay brain aging and improve outcomes for affected populations.

The startup has developed a molecular testing platform that utilizes low-cost tools for on-site analysis of DNA, RNA, and protein targets. This technology enables businesses to make real-time decisions regarding food quality and health by providing precise and accessible testing services.

Terraflos utilizes synthetic biology and cellular agriculture to produce high-value bioactive compounds from plant genetic information and stem cells, minimizing environmental impact. The startup addresses the growing demand for sustainable health and wellness solutions by providing optimized active ingredients for the cosmetic, food, nutraceutical, and pharmaceutical industries.

Kinzbio develops precision antimicrobial therapies using bacteriophages to target and eliminate specific bacterial pathogens. Their AI-driven platform rapidly identifies and optimizes phages for personalized treatments, offering a highly specific alternative to traditional antibiotics.

Comsentimento develops an AI-driven platform for clinical data transformation and research, focusing on enhancing cancer treatment and facilitating access to clinical trials. The platform provides healthcare professionals with actionable insights and support for chronic disease management, improving patient care and treatment adherence.

Yeda Health utilizes artificial intelligence to provide personalized dietary and lifestyle recommendations based on individual responses to food and continuous glucose monitoring data. This approach addresses the challenge of managing blood glucose levels by recognizing that each person's metabolic response is unique, enabling tailored strategies for metabolic stability.

The startup has developed a clinical research platform that utilizes machine learning to target the biological processes of aging, facilitating the discovery of therapies for age-related diseases such as cardiovascular and neurodegenerative conditions. By enabling pharmaceutical companies to enhance medical treatments, the platform addresses the need for more effective interventions in aging-related health issues.

GenAI is a platform that utilizes natural language processing to analyze customer feedback and extract actionable insights. By transforming unstructured data into structured information, it enables businesses to understand customer sentiment and improve their products and services.

Blue AI is a no-code AI platform that utilizes machine learning models, primarily XGBoost and natural language processing, to analyze health claims data for employers and healthcare providers in Latin America. It identifies potential fraud, unnecessary procedures, and predicts avoidable hospitalizations, enabling businesses to proactively manage healthcare costs and improve patient care efficiency.

The startup develops an all-in-one AI platform that integrates knowledge engineering into large enterprises through data engineering, customized models, and content creation tools. This technology enables businesses to optimize operations and drive growth by effectively managing and utilizing their data resources.

The startup offers an AI-driven platform that connects businesses with suitable partners throughout their innovation journey. By leveraging machine learning algorithms, it enhances strategic collaboration, enabling companies to identify and engage with startups that align with their specific needs.

Ai Bruna utilizes artificial intelligence to optimize production processes across various industries by predicting raw material characteristics and enhancing operational efficiency. The platform reduces production costs, energy usage, and waste while improving product quality and profitability through data-driven decision-making.

AIMedic utilizes artificial intelligence to integrate diverse medical data sources, enhancing diagnostic accuracy and treatment selection for healthcare professionals. The platform supports patient monitoring through an intelligent assistant, providing validated educational resources and vital health updates to improve patient outcomes.

Base Cientifica offers comprehensive molecular and cellular research services to accelerate preclinical development and personalized medicine. They specialize in biological assay validation, biobanking, and molecular diagnostic assay development using PCR and NGS. Their services also include preclinical efficacy and safety studies, 3D organoid cultivation, and AI-driven R&D optimization.

Fauna provides personalized gut health solutions through its gut insight test and prebiotic supplements. The company offers a holistic approach to wellness by analyzing an individual's microbiome and recommending targeted interventions to address root health issues naturally.

The startup operates a genomics platform that centralizes and integrates DNA data to provide precise diagnoses and personalized treatment plans through advanced data analysis and interpretation. By leveraging genomic information, the platform enables researchers to enhance health outcomes and preventive care strategies for individuals.

The startup has developed a molecular diagnostic platform that integrates advanced fluidics, engineering, and bioinformatics to create a user-friendly in vitro diagnostic system. This technology enables healthcare providers to deliver precise clinical genomic information to patients, enhancing accessibility to essential diagnostics for improved treatment outcomes.

The startup develops AI-powered applications that enhance decision-making by analyzing large datasets and providing actionable insights. This technology enables organizations to make data-driven choices more efficiently, reducing uncertainty and improving operational outcomes.

The startup develops gene therapies utilizing a biocompatible delivery system to facilitate targeted treatment of genetic diseases. This approach enhances the efficacy of therapeutic interventions, addressing the limitations of traditional treatment methods in the biotechnological market.

The startup utilizes a proprietary Generative Biology Platform and a Discovery Platform that integrate machine learning and multi-modal single-cell analysis to identify gene regulatory networks and develop targeted cell therapies for cancer. By precisely modulating gene expression in specific cell types, the company aims to enhance the efficacy of cell-based treatments, addressing the limitations of traditional cancer therapies.

Naturannova utilizes a computational platform that combines AI and bioinformatics to identify and analyze plant-based proteins, creating sustainable and clean label ingredients. The startup addresses the need for healthier food options by developing novel protein sources, such as their all-natural protein-based sweetener, through precision fermentation and laboratory testing.